Research Site
Oklahoma City, Oklahoma, 73104, United States
NCT Number: NCT00808769
The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Oklahoma City, Oklahoma, 73104, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
capsule(20 mg omeprazole/sodium bicarbonate), single dose
Omeprazole-magnesium 20.6 mg, tablet, single dose
Time frame: continuously over a 24 hour period
In this study, there was evidence of gastric pH probe failure and a high incidence of biologically improbable pH measurements (sustained pH < 1.0) that bring the validity of the results into question. The results of this study are, therefore, inconclusive.
Procter and Gamble
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.